Literature DB >> 31127783

Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.

Simon Dietlin1, Maria Soto1, Vera Kiyasova2, Maria Pueyo2, Adelaïde de Mauleon1, Julien Delrieu1, Pierre Jean Ousset1, Bruno Vellas1.   

Abstract

BACKGROUND: Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia.
OBJECTIVE: To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI.
METHODS: 96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study.
RESULTS: The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders.
CONCLUSION: Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD.

Entities:  

Keywords:  Alzheimer’s disease; dementia; mild cognitive impairment; neuropsychiatric zzm321990symptoms

Year:  2019        PMID: 31127783     DOI: 10.3233/JAD-190025

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.

Authors:  Xinting Ge; Yuchuan Qiao; Jiyoon Choi; Rema Raman; John M Ringman; Yonggang Shi
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

Authors:  Ranjan Duara; Warren Barker
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

Review 3.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

4.  Empirically defining the preclinical stages of the Alzheimer's continuum in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Andrew M Kiselica
Journal:  Psychogeriatrics       Date:  2021-04-22       Impact factor: 2.440

5.  Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.

Authors:  Myuri Ruthirakuhan; Zahinoor Ismail; Nathan Herrmann; Damien Gallagher; Krista L Lanctôt
Journal:  Alzheimers Dement       Date:  2022-02-01       Impact factor: 16.655

Review 6.  Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer's Disease and Related Dementias.

Authors:  William D Todd
Journal:  Front Neurosci       Date:  2020-09-03       Impact factor: 5.152

7.  Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults.

Authors:  Byron Creese; Ryan Arathimos; Helen Brooker; Dag Aarsland; Anne Corbett; Cathryn Lewis; Clive Ballard; Zahinoor Ismail
Journal:  Alzheimers Dement (Amst)       Date:  2021-03-17

8.  Relapse in Dementia-related Psychosis and Clinical Decisions.

Authors:  Maria Soto-Martin; Erin P Foff; Davangere P Devanand
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-02-09       Impact factor: 2.357

9.  Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer's and non-Alzheimer's dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-03-31       Impact factor: 6.982

10.  Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.

Authors:  Natalia Roberto; Maria J Portella; Marta Marquié; Montserrat Alegret; Isabel Hernández; Ana Mauleón; Maitee Rosende-Roca; Carla Abdelnour; Ester Esteban de Antonio; Juan P Tartari; Liliana Vargas; Rogelio López-Cuevas; Urszula Bojaryn; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Adelina Orellana; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Emilio Alarcón-Martín; Agustín Ruíz; Lluís Tárraga; Mercè Boada; Sergi Valero
Journal:  Front Aging Neurosci       Date:  2021-12-08       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.